HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio López-Vázquez Selected Research

MICB antigen

4/2008Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio López-Vázquez Research Topics

Disease

6Ankylosing Spondylitis
01/2016 - 11/2002
4Infections
01/2020 - 03/2004
3Autoimmune Diseases (Autoimmune Disease)
02/2014 - 04/2008
3Celiac Disease (Celiac Sprue)
02/2014 - 06/2005
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 03/2004
2Hepatocellular Carcinoma (Hepatoma)
07/2005 - 03/2004
2Crohn Disease (Crohn's Disease)
05/2003 - 09/2002
1Chronic Hepatitis C
06/2012
1Wounds and Injuries (Trauma)
10/2011
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2011
1Ventilator-Induced Lung Injury
10/2011
1Virus Diseases (Viral Diseases)
08/2011
1Disease Susceptibility (Diathesis)
07/2011
1HIV Infections (HIV Infection)
08/2009
1Neoplasms (Cancer)
08/2008
1Multiple Sclerosis
04/2008
1Relapsing-Remitting Multiple Sclerosis
04/2008
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2005
1End Stage Liver Disease
03/2004
1Arthritis (Polyarthritis)
05/2003
1Fistula
09/2002
1Psoriatic Arthritis
05/2002
1Hepatitis B
04/2002
1Fibrosis (Cirrhosis)
04/2002
1Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
04/2002

Drug/Important Bio-Agent (IBA)

4HLA-B Antigens (HLA-B)IBA
01/2016 - 11/2002
4micaIBA
02/2014 - 05/2002
4HLA-B27 Antigen (HLA B27 Antigen)IBA
11/2011 - 07/2008
2AminopeptidasesIBA
01/2020 - 07/2011
2Glutens (Glutelin)IBA
02/2014 - 03/2011
2Peptides (Polypeptides)IBA
02/2014 - 07/2011
2KIR ReceptorsIBA
01/2014 - 07/2005
2LigandsIBA
08/2008 - 04/2008
2HLA-DRB1 Chains (HLA DRB1)IBA
03/2004 - 05/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2003 - 09/2002
1AntibodiesIBA
02/2014
1Proteins (Proteins, Gene)FDA Link
02/2014
1AutoantibodiesIBA
02/2014
1HLA-DPA1 antigen (HLA DPA1)IBA
11/2011
1HLA-DPB1 antigen (HLA DPB1)IBA
11/2011
1Matrix Metalloproteinases (MMPs)IBA
10/2011
1AntigensIBA
08/2009
1MICB antigenIBA
04/2008
1HLA-C Antigens (HLA-C)IBA
11/2005
1EpitopesIBA
07/2005
1KIR3DS1 ReceptorsIBA
07/2005
1TransglutaminasesIBA
06/2005
1HLA-DR11 antigenIBA
03/2004
1Alanine Transaminase (SGPT)IBA
03/2004
1HLA-DQB1 antigen (HLA DQB1)IBA
03/2004
1HLA Antigens (Human Leukocyte Antigens)IBA
03/2004
1DNA (Deoxyribonucleic Acid)IBA
03/2004
1Monoclonal AntibodiesIBA
09/2002
1Interleukin-6 (Interleukin 6)IBA
09/2002
1CytokinesIBA
09/2002
1Acute-Phase Proteins (Acute-Phase Protein)IBA
09/2002
1Infliximab (Remicade)FDA Link
09/2002
1Transferrin (beta 2 Transferrin)IBA
04/2002
1IronIBA
04/2002
1Biomarkers (Surrogate Marker)IBA
04/2002

Therapy/Procedure

1Gluten-Free Diet
02/2014
1Therapeutics
06/2012
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
10/2011
1Transplantation
08/2011